# Contoura With Phorcides Compared to Wavefront Optimized LASIK

> **NCT05486546** · NA · RECRUITING · sponsor: **Daniel Terveen** · enrollment: 120 (estimated)

## Conditions studied

- Myopia
- Astigmatism

## Interventions

- **PROCEDURE:** Contoura with Phorcides
- **DEVICE:** WaveLight Wavefront Optimized

## Key facts

- **NCT ID:** NCT05486546
- **Lead sponsor:** Daniel Terveen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-15
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486546, "Contoura With Phorcides Compared to Wavefront Optimized LASIK". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05486546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*